TrianglePUBLICATIONS · 35271306
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2022 Jul 1
- First author
- Teachey DT
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Teachey DT
- type
- Author
- name
- Devidas M
- type
- Author
- name
- Wood BL
- type
- Author
- name
- Chen Z
- type
- Author
- name
- Hayashi RJ
- type
- Author
- name
- Hermiston ML
- type
- Author
- name
- Annett RD
- type
- Author
- name
- Archer JH
- type
- Author
- name
- Asselin BL
- type
- Author
- name
- August KJ
- type
- Author
- name
- Cho SY
- type
- Author
- name
- Dunsmore KP
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Teachey DT
- type
- Author
- name
- Devidas M
- type
- Author
- name
- Wood BL
- type
- Author
- name
- Chen Z
- type
- Author
- name
- Hayashi RJ
- type
- Author
- name
- Hermiston ML
- type
- Author
- name
- Annett RD
- type
- Author
- name
- Archer JH
- type
- Author
- name
- Asselin BL
- type
- Author
- name
- August KJ
- type
- Author
- name
- Cho SY
- type
- Author
- name
- Dunsmore KP
- type
- Author
- bibliography ids
- nci-bib-15a5c3b2dc81116f19c2d167
- book metadata
- content sha256
- 2c017defef0a7df51ddfe0e7282948bd72e0db3990915dd5248c49c052da4043
- document type
- citation
- dois
- 10.1200/JCO.21.02678
- electronic publication date
- display
- 2022 Mar 10
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35271306
- immutable id
- pubmed:35271306@2c017defef0a7df51ddfe0e7282948bd72e0db3990915dd5248c49c052da4043
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2106-2118
- volume
- 40
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 35271306
- provenance
- batch id
- 3f4d1914d2afe41e9e70
- provider
- NCBI PubMed ESummary
- record sha256
- 570c2b6f1bbddce9f8ac44fe75f137b729e8b776775402a7b0cebc8b302d34e6
- response sha256
- 0ceeb248a527e54c6f72dd28d20f7abec08a973fe2e10de00bede4895add09e7
- retrieved at
- 2026-09-09T23:48:06.522634+00:00
- publication date
- display
- 2022 Jul 1
- precision
- day
- year
- 2022
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
Preserved source evidence · Not medical advice